364results about How to "Quick elimination" patented technology

Disclosed are high density lipoprotein-nucleic acid particles, wherein the particles include (a) an apolipoprotein; (b) a nucleic acid component comprising a therapeutic nucleic acid segment; and (c) a polypeptide comprising a positively charged region, wherein the positively-charged region of the polypeptide associates with the nucleic acid component. Also disclosed are pharmaceutical compositions that include a) an apolipoprotein; (b) a nucleic acid component comprising a therapeutic nucleic acid segment; and (c) a polypeptide comprising a positively charged region. Methods that concern the particles and pharmaceutical compositions of the present invention are also set forth, as well as kits.

A portable remote control device enables user interaction with an appliance by detecting user gestures made in a hover zone, and converting the gestures to commands that are wirelessly transmitted to the appliance. The remote control device includes at least two cameras whose intersecting FOVs define a three-dimensional hover zone within which user interactions are imaged. Separately and collectively image data is analyzed to identify a relatively few user landmarks. Substantially unambiguous correspondence is established between the same landmark on each acquired image, and a three-dimensional reconstruction is made in a common coordinate system. Preferably cameras are modeled to have characteristics of pinhole cameras, enabling rectified epipolar geometric analysis to facilitate more rapid disambiguation among potential landmark points. As a result processing overhead and latency times are substantially reduced. Landmark identification and position information is convertible into commands that alter the appliance behavior as intended by the user's gesture.

Biocompatible intraocular implants include a tyrosine kinase inhibitor and a biodegradable polymer that is effective to facilitate release of the tyrosine kinase inhibitor into the vitreous of an eye for an extended period of time. The therapeutic agents of the implants may be associated with a biodegradable polymer matrix, such as a matrix that is substantially free of a polyvinyl alcohol. The implants can be placed in an eye to treat or reduce the occurrence of one or more ocular conditions.

The invention relates to the field of air pollutant removing devices, in particular to a haze pollutant removing device which comprises a ventilation system with a fan, an air filter device, purification devices and silencers. The ventilation system with the fan comprises a rainproof haze air inlet, an air pressure equalizing chamber, the fan and an air cleaning static pressure tank type spherical jet air outlet; the air filter device comprises a primary filter, an intermediate filter and a high-efficiency filter; the purification devices include one or a plurality of devices including an alkaline aqueous solution spray washing device, an activated carbon adsorption device, a negative ion purification device, a catalytic combustion purification device, an electrostatic dust collection device, an ultraviolet disinfection device, a photonic hydrogen ion purification device, a biological purification device and a three-way catalytic purification device; the silencers include one or a plurality of devices including a silencer at an induce draft end of the fan, a vibration damping muffler device and a silencer at an exhaust end. The haze pollutant removing device has the advantages that clean air can be exhausted to the atmosphere under the filter effects of filters and purification treatment effects of the various purification devices, and accordingly the purpose of quickly removing haze pollutants can be achieved.

The invention relates to novel pharmaceutical compositions for the systemic administration of pharmacologically active ingredients. The invention relates in particular to an injectable pharmaceutical composition comprising (a) a pharmacologically active ingredient in a solid phase, (b) a vehicle consisting substantially of polyol fatty acid esters with a degree of esterification of over 80%, and (c) a wetting agent consisting substantially of polyol fatty acid esters with a monoester proportion of over 60%. The inventive composition is used for the systemic administration of numerous pharmacologically active ingredients, whereby the ingredients are released from the pharmaceutical composition over a period of at least 12, preferably at least 24 hours.

An artificial plasma-like substance having at least one water soluble polysaccharide oncotic agent selected from the group consisting of high molecular weight hydroxyethyl starch, low molecular weight hydroxyethyl starch, dextran 40 and dextran 70, and albumin which is buffered by lactate and has a pre-administration pH of between 5 and 6.5 is disclosed. Also disclosed is an artificial plasma-like solution having at least two water soluble polysaccharide oncotic agents one of which is eliminated from the circulation slowly and the other of which is eliminated from the circulation quickly. Supplimentation of the plasma-like solution with certain ions is described. A system for administration of the plasma-like solution to a subject wherein the system comprises a first and second solution each having particular buffers is described. The plasma-like solution including cryoprotective adducts is also disclosed. The use of the plasma-like solution in organ transplant, novel chemotherapy procedures, and tissue, organ and organism cryopreservation are also disclosed.

Methods of treating MDS, or ameliorating a symptom thereof, are disclosed. Specific methods encompass the administration of one or more vitamin D compounds, or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer, clathrate, or prodrug thereof, alone or in combination with one or more additional active agents. Other methods include intermittent administration of a high dose of one or more vitamin D compounds, or a pharmaceutically acceptable salt, solvate, hydrate, stereoisomer, clathrate, or prodrug thereof, alone or in combination with one or more additional active agents. Such intermittent administration allows high doses of the vitamin D compounds to be administered while minimizing or eliminating hypercalcemia.

A ground-fault circuit-interrupter method and system for three-phase electrical power systems including a plurality of GFCI units and a processor forming a ground-fault circuit interrupting system for use in a three-phase power distribution network including a three-phase source of electrical power, a three- or four-wire main circuit, and a plurality of three- or four-wire feeder circuits connected across the main circuit. A GFCI unit is provided in the main circuit and in each of the feeder circuits. The processor is programmed to continuously monitor the main GFCI unit and each feeder GFCI unit to determine when and where a fault has occurred and, in response thereto, to interrupt the faulted circuit and to inhibit tripping of the non-faulted circuits. The novel GFCI system is applicable for solidly-grounded, resistance-grounded, or ungrounded as well as other three-phase systems.

A fabrication method of a semiconductor device according to the present invention includes the steps of: bonding a reinforcing plate with a front surface of a semiconductor wafer via a reinforcing plate, the reinforcing plate having holes and the semiconductor wafer bearing semiconductor devices; grinding a back surface of the semiconductor wafer; and detaching the reinforcing plate from the semiconductor wafer by injecting a solvent for dissolving an adhesive layer into the holes and by allowing the solvent to permeate through the adhesive layer. The method enables the reinforcing plate to be quickly detached from the semiconductor wafer without causing defects, such as bending and cracking, in the semiconductor wafer after the reinforcing plate is used to grind the semiconductor wafer.

The invention relates to a system of automatic vaccination of eggs, developed for the purpose of vaccinating large quantities of fertile eggs in order to reduce the costs and labor involved, reduce embryonic mortality by increasing protection from diseases and reduce the stress in the first day of life of poultry chicks by eliminating the process of manually vaccinating each chick. The invention comprises an automatic system controlled by a PLC (programmable logic controller), using an injector that has a cylindrical body and cap made from high density non-corrosive plastic and together they form a pneumatic chamber, the cap containing an electronic contact sensor to signal empty egg spaces and avoiding wasting vaccine. The injector's pneumatic chamber contains a plasticized fiber sleeve to permit smooth movement of the pneumatic plunger. A needle passes through the plunger and a double acting spring in addition to securing the plunger in its starting position and returning it to the original position after the injection of vaccine, reduces the pressure on the needle after it breaks the egg shell to avoid harming the embryo. The injection platform that has conical holes for the injectors to permit lateral movements that allows the injectors to accommodate eggs that are tilted, with the injectors locked into position by a series of air bladders located within the platform and running parallel to the injectors. The sanitization system which disinfects the needle and the part of the injector in contact with the egg after every single injection is coupled with the removal of the incubator trays from the vaccination area to economize on production time.

The invention provides an LOD model generation method based on a linear quadtree. The method comprises the following steps: performing linear quadtree segmentation on to-be-drawn terrain, storing data of the to-be-drawn terrain in a two-dimensional array, reading information of each node in the linear quadtree from the two-dimensional array through an index, storing leaf node information of the linear quadtree, organizing terrain nodes, enabling the terrain nodes in the linear quadtree to be stored in a one-dimensional array, establishing a terrain node evaluation mechanism on the basis that a static error and a dynamic error are considered, performing crack elimination on different segmentation levels of the adjacent terrain nodes, and obtaining an LOD model based on the linear quadtree. The method is applied to a terrain simplification aspect in a computer graphics and image field, and the terrain nodes are organized by utilizing a linear quadtree storage model and through combination use of a two-dimensional filling curve; on the basis that error factors are fully considered, the node evaluation mechanism is established, and a terrain crack problem is eliminated; and terrain drawing efficiency can be obviously improved.

A display panel with image sticking elimination circuit is provided. The image sticking elimination circuit can be applied in a display unit comprising a plurality of pixel units driven by a gate driving circuit and a data driving circuit. The gate driving circuit is driven by a first voltage and a second voltage. The first voltage turns on the pixel units for receiving data signals and the second voltage turns off the pixel units for preventing the pixel units from receiving data signals. A switch is coupled between a data line driven by the data driving circuit and an ESD circuit. The image sticking elimination circuit is charged by the first voltage and the charged power is output to turn on the switch and the pixel units when abnormal power shut down occurs.